• PRIALT should be administered intrathecally (IT) by a physician experienced with IT administration technique and familiar with the drug and device labeling 
• PRIALT is not intended for intravenous or epidural administration
• Intended for delivery through programmable implanted variable-rate microinfusion device (Medtronic SynchroMed^® EL, SynchroMed^® II Infusion System and the CADD-Micro^® ambulatory infusion pump). Click here to view detailed instructions for Delivery with Medtronic SynchroMed^® EL or SynchroMed^® II Infusion System.
• PRIALT is used for therapy either: undiluted (25 mcg/mL in 20 mL vial) or diluted (100 mcg/mL in 1 or 5 mL vials)
• Diluted PRIALT:
  • Prepared with 0.9% Sodium Chloride Injection, USP (preservative free) using aseptic procedures to the desired concentration prior to placement in the microinfusion pump
  • 100 mcg/mL formulation may be administered undiluted once an appropriate dose has been established                    

Prialt is available in multiple vial sizes and concentrations

Treatment Initiation Time Line